Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Gunther's disease)

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 217-220

  Zix Kieffer, I ^a   Langer, B ^b   Eyer, D ^a   Acar, G ^a   Racadot, E ^c   Schlaeder, G ^b   Oberlin, F ^d   Lutz, P ^a,e  

^a Institut De Puériculture   (France)

^b Gynecol Obstétrique II ^*  (France)

^c Centre Regional de Transfusion Sanguine   (France)

^d Service d'Hematologie   (France)

^e Institut de Puériculture   (France)

Author keywords

Bone marrow transplantation; Child; Congenital; Cord blood; Erythropoietic porphyria

Indexed keywords

HEME; UROPORPHYRINOGEN III SYNTHASE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CASE REPORT; CLINICAL FEATURE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; CYTOMEGALOVIRUS INFECTION; ENZYME DEFICIENCY; ERYTHROCYTE FRAGILITY; FACE; FEMALE; FINGER NAIL; GROWTH RETARDATION; HEME SYNTHESIS; HEMOLYTIC ANEMIA; HIRSUTISM; HUMAN; PHOTOSENSITIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCAR FORMATION; SKIN; STEM CELL TRANSPLANTATION; TOOTH; TOOTH COLOR; UMBILICAL CORD BLOOD; URINE;

AMNIOCENTESIS; COMBINED MODALITY THERAPY; FEMALE; FETAL BLOOD; FETAL DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PORPHYRIA, ERYTHROPOIETIC; PREGNANCY; SPLENECTOMY; TRANSPLANTATION CONDITIONING;

EID: 0029738227     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bottomley SS, Muller-Eberhard U. Pathophysiology of heme synthesis. Semin Hematol 1988; 25: 282-302.
2. Bickers DR, Poh-Fitzpatrick MB. Günther's disease and the changing complexion of human porphyria. Photodermatology 1986; 3: 315-316.
3. Moore MR, McColl KEL, Fitzsimons EJ et al. The porphyrias. Blood Rev 1990; 4: 88-96.
4. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Stanbury JB, Wyngaarden JB, Fredickson DS (eds). The Metabolic Basis of Inherited Disease. McGraw-Hill: New York, 1989, pp 1305-1365.
5. Kauffmann L, Evans DIK, Stevens RF, Weinkove C. Bone marrow transplantation for congenital erythropoietic porphyria. Lancet 1991; 337: 1510-1511.
6. Warner CA, Poh-Fitzpatrick VB, Zaider EF et al. Congenital erythropoietic porphyria: a mild variant with low uroporphyrin I levels due to a missense mutation (A66V) encoding residual uroporphyrinogen II synthase activity. Arch Dermatol 1992; 128: 1243-1248.
7. Oliveri MB, Mautalen C, Maega M et al. Congenital erythropoietic porphyria: skeletal manifestations and effect of pamidronate treatment. Bone 1994; 15: 101-104.
8. Rank JM, Straka JG, Weimer MK et al. Hematin therapy in late onset congenital erythropoietic porphyria. Br J Haematol 1990; 75: 617-622.
9. Boulechfar S, Da Silva V, Deybach JC et al. Heterogeneity of mutations in the uroporphyrinogen II synthase gene in congential erythropoietic porphyria. Hum Genet 1992; 88: 320-324.
10. Warner CA, Yoo HW, Tsai SF et al. Congenital erythropoietic porphyria: characterization of the genomic structure and identification of mutations in the uroporphyrinogen III synthase gene. Am J Hum Genet 1990; 47 (Suppl.): A83 (Abstr.).
11. Piomelli S, Poh-Fitzpatrick VB, Seaman C et al. Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. New Engl J Med 1986; 314: 1029-1031.
12. Deybach JCH, Grandchamp B, Grelier V et al. Prenatal diagnosis of congenital erythropoietic porphyria (Günther's disease) in a fetus at risk. Hum Genet 1980; 53: 217-221.
13. Tsai SF, Bishop DF, Desnick RJ. Human uroporphyrinogen III synthase: molecular cloning, nucleotide sequence, and expression of a full length cDNA. Prac Natl Acad Sci USA 1988; 85: 7049-7053.
14. Astrin KH, Warner CA, Yoo HW et al. Regional assignment of the human uroporphyrinogen II synthase gene to chromosome 10q25.2q26.3. Hum Genet 1991; 87: 18-22.
15. Mustajoki P, Tenhunen R, Pierach C et al. Heme in the treatment of porphyrias and haematologic disorders. Semin Hematol 1989; 26: 1-9.
16. Tishler PV, Winston SH. Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoal. Meth and Find Exp Clin Pharmacol 1990; 12: 645-648.
17. Tishler PV, Winston SH. Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitro. Meth and Find Exp Clin Pharmacol 1985; 7: 485-491.
18. Pimstine NR, Gandhi SN, Mukerji SK. Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. New Engl J Med 1987; 316: 390-393.
19. Maleville J, Babin JP, Mollard S et al. Porphyrie érythropoiétique congénitale de Gunther et caroténoïdes. Essai thérapeutique de 4 ans. Ann Dermatol Venereol 1982; 109: 883-887.
20. Mathews-Roth MM. Treatment of erythropoietic protoporphyria with beta-carotene. Photodermatology 1984; 1: 318-321.
21. Guarini L, Piomelli S. Hydroxyurea in congenital erythropoietic porphyria. New Engl J Med 1994; 330: 1091-1092.
22. De Verneuil H, Moreau-Gaudry F, Ged C et al. Porphyrie érythropoiétique congénitale. A propos d'un cas fatal en période néonatale dû à une hémolyse aiguë avec insuffisance hépatique. Arch Pédiatr 1995; 2: 755-761.
23. Broxmeyer HE, Gordon WD, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hemopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828-3832.
24. Gluckman E, Broxmeyer HE, Auerbach AD et al. Hematopoietic reconstitutuion in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. New Engl J Med 1989; 321: 1174-1178.
25. Wagner JE, Kenan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant diseases. Lancet 1995; 346: 214-219.